Talia spent 13 years studying the mechanisms of mental illness at Oxford, UCL and Columbia Universities. She then moved into the industry to become Principle Scientist at a White-House Endorsed early-stage company, developing personalized medicine tools for rare-genetic diseases. In 2018 she founded Genetika+ to match patients suffering from Major Depression with personalized drugs.
No items found.
We look forward to updating you on our future activities!